Form 8-K CVS HEALTH Corp For: May 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CVS Health (CVS) PT Lowered to $77 at BofA Securities
May 2, 2024 5:38 AM EDTBofA Securities analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $77.00 (from $95.00) while maintaining a Buy rating.
The analyst comments "Shares of CVS currently trade at 8x earnings, implying investors have substantial doubt the company can... More
CVS Health (CVS) stock tumbles as earnings, guidance miss expectations
May 1, 2024 6:55 AM EDT(Updated - May 1, 2024 11:42 AM EDT)
CVS Health (NYSE: CVS) reported a decline in first-quarter profits and slashed its full-year earnings outlook, sending shares down more than 17% Wednesday as both earnings and revenue fell short of Wall Street expectations. The healthcare giant posted adjusted earnings per share (EPS) of $1.33 for the quarter, which was significantly below the analyst consensus of $1.71. Revenue for the quarter was $88.4 billion, also missing the consensus estimate of $89.33 billion.
The company's first-quarter revenue saw a 3.7% increase compared to the same period last year, driven by growth in the Health Care... More
